Aethlon Medical (AEMD) Equity Ratio (2016 - 2024)
Historic Equity Ratio for Aethlon Medical (AEMD) over the last 14 years, with Q4 2024 value amounting to 0.66.
- Aethlon Medical's Equity Ratio fell 892.29% to 0.66 in Q4 2024 from the same period last year, while for Dec 2024 it was 0.66, marking a year-over-year decrease of 892.29%. This contributed to the annual value of 0.7 for FY2024, which is 1872.24% down from last year.
- As of Q4 2024, Aethlon Medical's Equity Ratio stood at 0.66, which was down 892.29% from 0.68 recorded in Q3 2024.
- Aethlon Medical's Equity Ratio's 5-year high stood at 0.96 during Q3 2021, with a 5-year trough of 0.66 in Q4 2024.
- Its 5-year average for Equity Ratio is 0.84, with a median of 0.87 in 2022.
- In the last 5 years, Aethlon Medical's Equity Ratio soared by 548708.79% in 2020 and then plummeted by 1872.24% in 2024.
- Quarter analysis of 5 years shows Aethlon Medical's Equity Ratio stood at 0.9 in 2020, then rose by 3.95% to 0.94 in 2021, then dropped by 11.12% to 0.83 in 2022, then dropped by 12.53% to 0.73 in 2023, then fell by 8.92% to 0.66 in 2024.
- Its Equity Ratio stands at 0.66 for Q4 2024, versus 0.68 for Q3 2024 and 0.76 for Q2 2024.